Giant Cell Tumor of Bone
📧 Sign up to get email alerts when something new happens for Giant Cell Tumor of Bone.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone [Phase 3]
This entry reports a Phase 3 clinical trial evaluating the effect of local bisphosphonates on recurrence rates in extremity giant cell tumor…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas [Phase 2]
Phase 2 study of LN-145 (LN-145-S1) in relapsed or refractory ovarian cancer, triple-negative breast cancer, anaplastic thyroid cancer, oste…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: PROMIS and Mobility Evaluation in Sarcoma Patients
A clinical trial is evaluating PROMIS and mobility in sarcoma patients and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study [Phase 1, Phase 2]
This clinical trial update describes a prospective, single-center study evaluating indocyanine green (ICG)–based near-infrared imaging to gu…
-
CLINICAL_TRIALS research · 2013-08-30Clinical Trial Update: Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study evaluating zoledronate (Zometa) in giant cell tumor of bone, which has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.